CNBC 快讯 4月10日 06:38 LLY印度市场份额下滑，Novo Nordisk在仿制减重药冲击下坚守阵地 Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep pr… FG 100 读报告 →